A phase II study of gemcitabine in combination with oxaliplatin as first line chemotherapy in patients with inoperable biliary tract adenocarcinoma

被引：0
|
作者：
Kim, H. [1 ]
Lee, S. [2 ]
Bae, S. [3 ]
Kim, C. [1 ]
Lee, N. [2 ,3 ]
Lee, K.
Park, S. [1 ]
Won, J. [1 ,2 ]
Hong, D.
Park, H. [2 ]
机构：
[1] Soonchunhyang Univ Hosp, Puchon, South Korea
[2] Soonchunhyang Univ Hosp, Seoul, South Korea
[3] Soonchunhyang Univ Hosp, Cheonan, South Korea
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71062-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3559
引用
收藏
页码：277 / 277
页数：1
相关论文
共 50 条
  • [1] A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
    Hyun Jung Kim
    Nam Su Lee
    Sang-Cheol Lee
    Sang Byung Bae
    Chan Kyu Kim
    Young Gook Cheon
    Young Seok Kim
    Jong Ho Moon
    Young Deok Cho
    Sang Heum Park
    Kyu Taek Lee
    Sung Kyu Park
    Jong-Ho Won
    Hee Sook Park
    Dae Sik Hong
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 371 - 377
  • [2] A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
    Kim, Hyun Jung
    Lee, Nam Su
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Cheon, Young Gook
    Kim, Young Seok
    Moon, Jong Ho
    Cho, Young Deok
    Park, Sang Heum
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Park, Hee Sook
    Hong, Dae Sik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 371 - 377
  • [3] Phase II study of gemcitabine and oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
    Kim, H.
    Lee, S.
    Bae, S.
    Kim, C.
    Lee, N.
    Lee, K.
    Park, S.
    Won, J.
    Hong, D.
    Park, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
    Graham J.S.
    Boyd K.
    Coxon F.Y.
    Wall L.R.
    Eatock M.M.
    Maughan T.S.
    Highley M.
    Soulis E.
    Harden S.
    Bützberger-Zimmerli P.
    Evans T.R.J.
    BMC Research Notes, 9 (1)
  • [5] Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
    Thongprasert, S
    Napapan, S
    Charoentum, C
    Moonprakan, S
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 279 - 281
  • [6] Gemcitabine and oxaliplatin (GEMOX) as first-line chemotherapy in advanced biliary tract adenocarcinoma:: Preliminary results of a phase II study
    Rozzi, A.
    Corona, M.
    Nardoni, C.
    Petricola, F.
    Calabro, P.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2007, 18 : 17 - 17
  • [7] A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers.
    Gebbia, N
    Verderame, F
    Di Leo, R
    Santangelo, D
    Cicero, G
    Valerio, MR
    Arcara, C
    Badalamenti, G
    Fulfaro, F
    Carreca, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 340S - 340S
  • [8] A phase II study of oxaliplatin in combination with doxorubicin as first-line chemotherapy in patients with inoperable hepatocellular carcinoma
    Lim, H.
    Uhm, J.
    Park, J.
    Park, Y.
    Park, S.
    Lee, J.
    Kang, W.
    Ahn, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 43 - 43
  • [9] Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma - A multicenter phase II study
    Androulakis, Nikolaos
    Aravantinos, Gerasimos
    Syrigos, Kostas
    Polyzos, Aris
    Ziras, Nikolaos
    Tselepatiotis, Evangelos
    Samonis, George
    Kentepozidis, Nikolaos
    Giassas, Stylianos
    Vamvakas, Lambros
    Georgoulias, Vassilis
    ONCOLOGY, 2006, 70 (04) : 280 - 284
  • [10] A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma
    Uhm, Ji Eun
    Park, Joon Oh
    Lee, Jeeyun
    Park, Young Suk
    Park, Se Hoon
    Yoo, Byung Chul
    Paik, Seung Woon
    Koh, Kwang Cheol
    Kang, Won Ki
    Lim, Ho Yeong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (05) : 929 - 935
12345